Form 4: Cara Therapeutics Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Joana Goncalves, Chief Medical Officer of Cara Therapeutics, sold 3,293 shares of common stock to cover tax withholding obligations.
Summary
- On February 29, 2024, Joana Goncalves, the Chief Medical Officer of Cara Therapeutics, Inc., sold 3,293 shares of common stock.
- The sale was executed at a price of $0.89 per share.
- Following the transaction, Goncalves directly owns 56,118 shares of Cara Therapeutics.
- The sale was conducted under a pre-arranged 'sell to cover' arrangement adopted on March 12, 2020, to satisfy tax obligations related to the vesting of restricted stock units.
Sentiment
Score: 5
Explanation: The document describes a routine stock sale to cover tax obligations, which is neither particularly positive nor negative.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company officers and directors. This particular filing indicates a sale to cover tax obligations, which is a common practice.
Stakeholder Impact
- The sale of shares by an officer could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 2020-03-12 | Date the reporting person adopted the 'sell to cover' arrangement. |
| 2024-02-29 | Date of the stock sale transaction. |
| 2024-03-04 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.